International Journal of Nutrition, Pharmacology, Neurological Diseases

CASE REPORT
Year
: 2013  |  Volume : 3  |  Issue : 1  |  Page : 73--76

Hypothesis: Are beta-blockers safe for patients with multiple sclerosis?


Auda Fares 
 Department of Internal Medicine, St. Johannes Hospital, Germany

Correspondence Address:
Auda Fares
Wilhelm-Busch-Straße 9, 53844 Troisdorf
Germany

Beta-adrenergic receptor blockers are an important class of drugs in the management of patients with cardiovascular diseases. Patients with multiple sclerosis have a higher risk of cardiovascular diseases than the general population. Melatonin has been implicated in the pathogenesis and clinical course of MS. When melatonin levels decline, an exacerbation of MS symptoms is seen. Beta-blockers have been shown to reduce the production of melatonin. Various central nervous system side effects associated with using of beta-blockers are linked with reduction of melatonin levels. Exogenous melatonin administration as a supplement in MS patients taking beta-blockers could reduce the central nervous system side effects as well as decrease diseases progression.


How to cite this article:
Fares A. Hypothesis: Are beta-blockers safe for patients with multiple sclerosis?.Int J Nutr Pharmacol Neurol Dis 2013;3:73-76


How to cite this URL:
Fares A. Hypothesis: Are beta-blockers safe for patients with multiple sclerosis?. Int J Nutr Pharmacol Neurol Dis [serial online] 2013 [cited 2022 Aug 18 ];3:73-76
Available from: https://www.ijnpnd.com/article.asp?issn=2231-0738;year=2013;volume=3;issue=1;spage=73;epage=76;aulast=Fares;type=0